A critical vulnerability

Andrea Morandi: A critical vulnerability in triple-negative breast cancer

Andrea Morandi, Professor at University of Florence, shared on LinkedIn:

“I’m thrilled to share our latest research out in EMBO Molecular Medicine uncovering a critical vulnerability in triple-negative breast cancer. This discovery opens new avenues for innovative treatments by targeting specific enzymes and leveraging ferroptosis.”

Альтернативный текст для этого изображения не предоставлен

Source: Andrea Morandi/LinkedIn

 

Andrea Morandi Breast Cancer cancer EMBO Molecular Medicine OncoDaily Oncology triple-negative breast cancer